MedPath

Burel Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

FDA:20

Drug Approvals

Carglumic acid

Approval Date
Mar 19, 2024
FDA

Pantoprazole Sodium

Approval Date
Feb 16, 2024
FDA

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

Approval Date
Dec 7, 2023
FDA

NICARDIPINE HYDROCHLORIDE

Approval Date
Sep 7, 2023
FDA

KETOCONAZOLE

Approval Date
Aug 1, 2023
FDA

tadalafil

Approval Date
Mar 25, 2023
FDA

Ketorolac Tromethamine

Approval Date
Mar 15, 2023
FDA

Sodium Fluoride 1.1%

Approval Date
Dec 16, 2022
FDA

Sodium Fluoride 5000 ppm

Approval Date
Dec 16, 2022
FDA

BUTALBITAL AND ACETAMINOPHEN

Approval Date
Dec 15, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.